Analytical Data
-
Gene name
C5orf51
- Application
-
Alternative Names
C5orf51UPF0600 Protein C5orf51
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A6NDU8
-
Expression Region
2-294aa
-
AA Sequence
AAAVSSVVR RVEELGDLAQ AHIQQLSEAA GEDDHFLIRA SAALEKLKLL CGEEKECSNP SNLLELYTQA ILDMTYFEEN KLVDEDFPED SSSQKVKELI SFLSEPEILV KENNMHPKHC NLLGDELLEC LSWRRGALLY MYCHSLTKRR EWLLRKSSLL KKYLLDGISY LLQMLNYRCP IQLNEGVSFQ DLDTAKLLSA GIFSDIHLLA MMYSGEMCYW GSKYCADQQP ENHEVDTSVS GAGCTTYKEP LDFREVGEKI LKKYVSVCEG PLKEQEWNTT NAKQILNFFH HRCN
-
Molecular Weight
33.6 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C5orf51, also known as Chromosome 5 Open Reading Frame 51, has garnered attention in recent years due to its role in various biological processes and its potential implications in human health. Initial studies indicated that C5orf51 is involved in cellular functions such as proliferation and differentiation, making it a candidate for investigation in relation to diseases like cancer and neurodegenerative disorders. Given the increasing incidence of these diseases globally, understanding the molecular mechanisms associated with C5orf51 is of paramount importance. Researchers have focused on characterizing its recombinant protein form to elucidate its structure-function relationship, which is crucial for identifying potential therapeutic targets. Furthermore, the development of C5orf51 recombinant protein can facilitate the study of its interactions with other proteins and cellular pathways. This work is particularly relevant in the context of developing novel biomarkers for disease diagnosis and treatment strategies. The recombinant protein produced through various expression systems allows for the exploration of C5orf51's functional roles in vitro and in vivo, advancing our understanding of its biological significance. Ultimately, thorough investigation of C5orf51 and its recombinant protein may contribute to the discovery of innovative approaches to combat diseases associated with its dysregulation.
